Supplementary Figure S5 from Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment

Abstract

Supp Figure S5. Tumor growth of parental B16-F10 and B16-F10 Jak2 KOs after virus injection